Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phase I and Phase II enzyme polymorphisms and childhood cancer.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research - 1 Sept 2006

Swinney Ryan, Hsu Stephanie, Tomlinson Gail

Abstract excerpt

Childhood cancers continue to be challenging clinical entities whose etiology, demographic characteristics, clinical progression, treatment efficacy, and outcomes remain incompletely understood. Research suggests that multiple environmental and genetic factors may play crucial roles in the pathophysiology of many of these malignancies. Recent attention has been directed to the role of carcinogen metabolizing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to Child, Preschool
Share to Cytochrome P-450 Enzyme System

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Glucuronosyltransferase

Share to Glutathione Transferase

Share to Infant

Share to Neoplasms

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 17134614
DOI: 10.2310/6650.2006.05062

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phase I and Phase II enzyme polymorphisms and childhood cancer.PMID 17134614Read ↗

Ethnic and genetic differences in metabolism genes and risk of toxicity and cancer.Semantic proximity Read ↗

Childhood acute lymphoblastic leukemia: genetic determinants of susceptibility and disease outcome.Semantic proximity Read ↗

Cytochrome P450 2W1 (CYP2W1) in Colorectal CancersSemantic proximity Read ↗

Genetic polymorphisms and metabolism of endocrine disruptors in cancer susceptibility.Semantic proximity Read ↗

Cancer and molecular biomarkers of phase 2.Semantic proximity Read ↗

The Ontogeny of Human Drug-Metabolizing Enzymes: Phase I Oxidative EnzymesSemantic proximity Read ↗

Polymorphisms in drug-metabolizing genes and urinary bladder cancer susceptibility and prognosis: Possible impacts and future management.Semantic proximity Read ↗

Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene PolymorphismsSemantic proximity Read ↗

[Genetic polymorphisms in xenobiotic metabolizing enzymes as a determinant of susceptibility to environmental mutagens and carcinogens in humans].Semantic proximity Read ↗

Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.Semantic proximity Read ↗

Polymorphism of CYP450 and cancer susceptibility.Semantic proximity Read ↗

Chronic health conditions in childhood cancer survivors: is it all treatment-related--or do genetics play a role?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.